Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
- 5 February 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Hepatology International
- Vol. 2 (1), 102-110
- https://doi.org/10.1007/s12072-007-9022-5
Abstract
The 2 reported trials investigated the effectiveness of treatment with peginterferon alfa-2a in Asian patients with chronic hepatitis B (CHB).Keywords
This publication has 52 references indexed in Scilit:
- 43 A multicenter, randomized, open-label study of peginterferon alpha-2b vs interferon alpha-2b for the treatment of chinese patients with HBeAg+VE chronic hepatitis BJournal of Hepatology, 2006
- 57 Long-term incidence of adefovir dipivoxil (ADV) resistance in chronic hepatitis B (CHB) patients after 144 weeks of therapyJournal of Hepatology, 2004
- Preventing and treating hepatitis B infectionBMJ, 2004
- Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis BThe New England Journal of Medicine, 2004
- Interferon-α for HBeAg-positive chronic hepatitis BJournal of Hepatology, 2003
- Effect of virological response on post‐treatment durability of lamivudine‐induced HBeAg seroconversionJournal of Viral Hepatitis, 2002
- The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis BJournal of Hepatology, 2001
- Peginterferon-??-2a (40kD)Drugs, 2001
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesThe New England Journal of Medicine, 1999
- Comparative study of three doses of interferon-α2a in chronic active hepatitis BJournal of Viral Hepatitis, 1994